Research
Online Inquiry

Coelenterazine h

Cat.No: RESK-0270 Datasheet

Quantities:
- +
Product Details Related Products
Product Name Coelenterazine h
Catalog No. RESK-0270
Description Coelenterazine h is a dehydroxylated derivative of native coelenterazine. It serves as a substrate for Renilla luciferase (Rluc) and as a cofactor of aequorin, producing a luminescence intensity more than 10-fold higher than that of native coelenterazine, making it well suited for reporter gene assays. It is also a cofactor of aequorin and can be used for the detection of calcium ion concentration in living cells, gene reporter assays, bioluminescence resonance energy transfer (BRET) studies, ELISA, high-throughput screening (HTS), and chemiluminescent detection of ROS levels in tissues or cells.
Intended Use Reporter gene assays; detection of calcium ion concentration in living cells; BRET (bioluminescence resonance energy transfer) studies; ELISA; high-throughput screening (HTS); chemiluminescent detection of ROS levels in tissues or cells.
For research use only.
Principle / Technology Coelenterazine h is oxidized by Renilla luciferase (Rluc) or by aequorin (in the presence of Ca2+) to generate bioluminescence. As a dehydroxylated derivative of native coelenterazine, it yields a luminescence intensity more than 10-fold higher than native coelenterazine.
Detection Method Bioluminescence / chemiluminescence detection using a luminometer or scintillation counter equipped with a bioluminescence detection module; small-animal in vivo imaging systems are also applicable. Fluorescence microscopy is not suitable.
Sample Type Cultured cells, tissues, cell lysates, and living animals (in vivo imaging).
Performance Range / Specifications English synonyms: 2-Deoxycoelenterazine; CLZN-h; h-CTZ
CAS NO.: 50909-86-9
Formula: C26H21N3O2
Molecular weight: 407.5 g/mol
Appearance: Yellow solid
Solubility: Soluble in methanol and ethanol; insoluble in DMSO
Purity (TLC): >99%
Luminescence intensity: >10-fold higher than native coelenterazine
Reaction Conditions / Protocol Stock solution (12 mM, ~5 mg/mL, 5x): Dissolve 1 mg of coelenterazine h powder directly in 197 uL of acidified methanol (100% methanol containing 20 uL/mL of 3 M or 6 M HCl).
Working solution (in vitro, example): 10 uM for approximately 1x10^5 cells. The optimal working concentration should be determined empirically by titration according to the relevant literature.
Detection timing: For in vitro assays, detect immediately after 10-15 min of cell incubation; for in vivo assays, detect within 10-15 min after injection.
It is recommended to establish a luciferase kinetic curve in a preliminary experiment to determine the time of peak signal and the signal plateau.
Components / Formulation Coelenterazine h (2-Deoxycoelenterazine), yellow solid powder.
Storage Conditions Store the powder at -20 °C protected from light in a dry environment, preferably under inert gas and avoiding contact with air. For long-term storage, keep at -70 °C.
Shelf Life 2 years when stored at -70 °C.
Package Specifications 1x 500 ug
2x 500 ug
5 mg
2x 5 mg
Product Form Yellow solid powder.
Quality Control Purity >99% as determined by TLC.
Purity >99% (TLC)
Molecular Weight 407.5 g/mol
Source / Origin Synthetic derivative of native coelenterazine (dehydroxylated form).
Shipping Conditions Shipped with ice packs.
Expiration Date / Stability Stable for 2 years when stored long-term at -70 °C protected from light and air.
Compatibility Compatible with Renilla luciferase (Rluc)-based reporter systems and aequorin-based calcium detection; suitable for BRET, ELISA, and HTS formats.
Recommended Buffer System Stock solutions are prepared in acidified methanol (100% methanol containing 20 uL/mL of 3 M or 6 M HCl); 1,2-propylene glycol and anhydrous ethanol may also be used as formulation solvents.
Application Notes / Precautions Working concentrations cited from the literature are for reference only; perform a concentration gradient to determine the optimal concentration.
The compound is readily oxidized; for in vivo imaging, a ready-to-use formulation is recommended because injection and anesthesia prolong the procedure, whereas in vitro detection is rapid and unaffected.
Ensure that the detection instrument (e.g., a multifunctional microplate reader) is equipped with a bioluminescence detection module.
Protect from light and air during handling and storage.

For research use only, not for clinical use.

0
0

There is no product in your cart.